Leucine

Leucine is one of nine essential amino acids, meaning the body cannot synthesise it and it must come from diet. It is also one of the three branched-chain amino acids, alongside isoleucine and valine, named for their branched molecular structure.

It occupies a special position in muscle physiology. Unlike most amino acids, which serve mainly as building material, leucine also functions as a signalling molecule that tells muscle cells to begin building protein. This dual role is why it receives so much attention relative to the other eighteen.

Dietary sources are simply protein foods. Whey is unusually leucine-rich at roughly 10 to 12 per cent, which is much of why it outperforms other proteins for muscle purposes. Meat, eggs and dairy supply around 8 per cent; most plant proteins less, which is why plant-based eaters often need slightly more total protein for the same effect.

Leucine activates mTORC1, the central regulator of protein synthesis in muscle cells. Rising intracellular leucine is detected by sensor proteins, which release the brake on mTORC1 and switch on the machinery that translates messenger RNA into new muscle protein.

This produces what is known as the leucine threshold: a meal must supply enough leucine to trigger a meaningful protein synthesis response, generally cited as around 2.5 to 3 grams for younger adults. Below that the signal is weak regardless of how much other protein is present.

The critical limitation is that signalling and substrate are different things. Leucine flips the switch, but building muscle protein requires all twenty amino acids present in adequate amounts. Triggering synthesis without the raw materials to complete it achieves very little, and this is the single most misunderstood point in the amino acid category.

The mechanistic evidence is strong and well replicated. Studies measuring muscle protein synthesis directly have repeatedly confirmed the leucine threshold and the dose-response relationship between leucine content of a meal and the synthetic response.

Where the picture changes is with isolated supplementation. Trials adding leucine to diets already containing adequate protein have generally found little or no additional benefit to muscle mass or strength. The threshold is usually already being met by ordinary meals.

The population where leucine supplementation shows more promise is older adults, who exhibit anabolic resistance and require a higher leucine dose to mount the same response. Adding leucine to lower-protein meals in this group has produced more encouraging results, and that is the clearest legitimate use case.

Leucine is a normal dietary component consumed in gram quantities daily by anyone eating protein, and supplemental doses are well tolerated. Digestive discomfort is the occasional complaint, and the taste is notably bitter.

One genuine consideration is amino acid competition. Branched-chain amino acids share a transporter with tryptophan and tyrosine, so large isolated doses can reduce their entry into the brain, with knock-on effects on neurotransmitter production. This is one reason isolated BCAA use is less benign than it appears.

Very high intakes may raise blood ammonia. Anyone who has been advised to limit specific amino acids in their diet should avoid supplemental leucine, and anyone taking regular medication should check before use.